Delivery Order SPE2DB22D3501-SPE2DB26FTF30
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,306.88 to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28-count units) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider...
- The Defense Logistics Agency awarded a delivery order valued at $2,133.86 to AmerisourceBergen Drug Corp for the supply of Imiquimod 3.75% cream (28 units) on August 7, 2025, with completion scheduled for August 8, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Imiquimod 3.75% cream (28 count) with a ceiling value of $1,628.06 under a firm fixed price contract type. The award was made on September 2, 2025, with an ultimate completion date of September 3, 2025, and was not designated as a set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the delivery order at its...
- The Defense Logistics Agency awarded a delivery order valued at $1,355.21 to AmerisourceBergen Drug Corp for Imiquimod 5% Cream in 24-packet units. This non-competitive, firm fixed-price delivery order was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters location. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,274.31 on August 21, 2025, with an ultimate completion date of August 22, 2025. The order is for Imiquimod 3.75% cream in 28-count units, a topical immunomodulatory medication used primarily for treating certain skin conditions. This non-set-aside, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Imiquimod 3.75% cream in 28-count packages, with a ceiling value of $17,482.59 and a period of performance through April 17, 2024. Amerisourcebergen, a major pharmaceutical distributor, leverages its extensive supply chain network to fulfill government contracts, particularly for the Department...
- This is a $1,560.19 firm fixed-price delivery order awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Imiquimod 5% Cream Packets, with a completion date of June 17, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, which provides a comprehensive global...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,325.66 by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Imiquimod 5% Cream in packets of 24 units. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters. This delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Imiquimod 5% cream, a prescription medication, with a ceiling value of $3,713.31 and a period of performance through April 9, 2024. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a larger...
- The Defense Logistics Agency awarded a $21,578.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562100604 Imiquimod 3.75% Cream 28s. The place of performance is Conshohocken, Pennsylvania. The period of performance is September 8-11, 2023. This delivery order was awarded under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. No subcontractors or set-aside designations...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTF30Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Imiquimod 3.75% cream (28-count units) under a firm fixed-price contract with a ceiling value of $1,161.37. This is a non-set-aside competitive award with an ultimate completion date of October 24, 2025, with performance to be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under a larger indefinite delivery vehicle. This award falls under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen maintains an extensive portfolio of competitive awards with the Defense Logistics Agency and its Medical Supply Chain, providing critical pharmaceutical support to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 10/23/25 |